Allergan

Actavis completed the acquisition of Allergan recently, creating a global pharmaceutical company and a leader in a new industry model - Growth Pharma. The combined company has broad commercial reach extending across approximately 100 countries and is anchored by strong and sustainable brand franchises, a leading global generics business, a premier pipeline. The company portfolio features six blockbuster franchises in key therapeutic categories, including Dermatology and Aesthetics; CNS; Eye Care; Women’s Health and Urology; GI; Cystic Fibrosis; Cardiovascular and Infectious Disease.

Driving continued innovation and growth is the company’s strong commitment and investment in R&D, focused on the development of innovative and value-enhancing products.

Show On Map